BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16380253)

  • 21. Triterpenes from leaves of Cheiloclinium cognatum and their in vivo antiangiogenic activity.
    Pereira RCG; Soares DCF; Oliveira DCP; de Sousa GF; Vieira-Filho SA; Mercadante-Simões MO; Lula I; Silva-Cunha A; Duarte LP
    Magn Reson Chem; 2018 May; 56(5):360-366. PubMed ID: 29388257
    [No Abstract]   [Full Text] [Related]  

  • 22. Gold(III) Salen complex-catalyzed synthesis of propargylamines via a three-component coupling reaction.
    Lo VK; Liu Y; Wong MK; Che CM
    Org Lett; 2006 Apr; 8(8):1529-32. PubMed ID: 16597102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives.
    da Costa PM; da Costa MP; Carvalho AA; Cavalcanti SM; de Oliveira Cardoso MV; de Oliveira Filho GB; de Araújo Viana D; Fechine-Jamacaru FV; Leite AC; de Moraes MO; Pessoa C; Ferreira PM
    Chem Biol Interact; 2015 Sep; 239():174-83. PubMed ID: 26134001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient synthesis of exo-olefinated deoxoartemisinin derivatives by Ramberg-Bäcklund rearrangement.
    Oh S; Jeong IH; Lee S
    J Org Chem; 2004 Feb; 69(3):984-6. PubMed ID: 14750835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyridoxine-derived bicyclic amido-, ureido-, and carbamato-pyridinols: synthesis and antiangiogenic activities.
    Lee H; Kim DG; Banskota S; Lee YK; Nam TG; Kim JA; Jeong BS
    Org Biomol Chem; 2014 Nov; 12(43):8702-10. PubMed ID: 25255328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syntheses of fumagillin and ovalicin.
    Yamaguchi J; Hayashi Y
    Chemistry; 2010 Apr; 16(13):3884-901. PubMed ID: 20209516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel pyrazole derivatives: synthesis and evaluation of anti-angiogenic activity.
    Christodoulou MS; Liekens S; Kasiotis KM; Haroutounian SA
    Bioorg Med Chem; 2010 Jun; 18(12):4338-50. PubMed ID: 20493716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and antiangiogenic effects of a series of potent novel fumagillin analogues.
    Lee HW; Cho CS; Kang SK; Yoo YS; Shin JS; Ahn SK
    Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):1024-9. PubMed ID: 17603194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of angiogenesis and inflammation by an extract of red clover (Trifolium pratense L.).
    Krenn L; Paper DH
    Phytomedicine; 2009 Dec; 16(12):1083-8. PubMed ID: 19665361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent advances in the study of artemisinin-related 1,2,4-trioxanes and ozonides (1,2,4-trioxolanes) as antimalarials].
    Yang ZS; Li Y
    Yao Xue Xue Bao; 2005 Dec; 40(12):1057-63. PubMed ID: 16496665
    [No Abstract]   [Full Text] [Related]  

  • 31. The gelatin sponge-chorioallantoic membrane assay.
    Ribatti D; Nico B; Vacca A; Presta M
    Nat Protoc; 2006; 1(1):85-91. PubMed ID: 17406216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-angiogenic activity of the methanol extract and its fractions of Ulmus davidiana var. japonica.
    Jung HJ; Jeon HJ; Lim EJ; Ahn EK; Song YS; Lee S; Shin KH; Lim CJ; Park EH
    J Ethnopharmacol; 2007 Jun; 112(2):406-9. PubMed ID: 17428629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin.
    Jones-Brando L; D'Angelo J; Posner GH; Yolken R
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4206-8. PubMed ID: 17060514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progress in studies on the artemisinin (qinghaosu)-type antimalarials].
    Chen Y; Zhu SM; Chen HY
    Yao Xue Xue Bao; 1998; 33(3):234-9. PubMed ID: 11938970
    [No Abstract]   [Full Text] [Related]  

  • 35. FGFR1/PI3K/AKT signaling pathway is a novel target for antiangiogenic effects of the cancer drug fumagillin (TNP-470).
    Chen GJ; Weylie B; Hu C; Zhu J; Forough R
    J Cell Biochem; 2007 Aug; 101(6):1492-504. PubMed ID: 17295210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonamides as antimitotics. Antiproliferative, antiangiogenic and antitumoral activity, and quantitative structure-activity relationships.
    Fortin S; Wei L; Moreau E; Lacroix J; Côté MF; Petitclerc E; Kotra LP; Gaudreault RC
    Eur J Med Chem; 2011 Nov; 46(11):5327-42. PubMed ID: 21920638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An in vivo role for Trypanosoma cruzi calreticulin in antiangiogenesis.
    Molina MC; Ferreira V; Valck C; Aguilar L; Orellana J; Rojas A; Ramirez G; Billetta R; Schwaeble W; Lemus D; Ferreira A
    Mol Biochem Parasitol; 2005 Apr; 140(2):133-40. PubMed ID: 15760653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane.
    Nap AW; Dunselman GA; Griffioen AW; Mayo KH; Evers JL; Groothuis PG
    Fertil Steril; 2005 Mar; 83(3):793-5. PubMed ID: 15749522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antiangiogenic activity of 6-amido-2,4,5-trimethylpyridin-3-ols.
    Lee H; Banskota S; Kim DG; Been JH; Jin YJ; Gautam J; Jang H; Nam TG; Kim JA; Jeong BS
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3131-6. PubMed ID: 24894557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
    Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.